4/16
04:29 pm
gkos
Glaukos Announces the Release of its 2023 Sustainability Report [Yahoo! Finance]
Low
Report
Glaukos Announces the Release of its 2023 Sustainability Report [Yahoo! Finance]
4/16
04:05 pm
gkos
Glaukos Announces the Release of its 2023 Sustainability Report
Low
Report
Glaukos Announces the Release of its 2023 Sustainability Report
4/15
09:53 am
gkos
Here's Why You Should Retain Glaukos (GKOS) Stock for Now [Yahoo! Finance]
Low
Report
Here's Why You Should Retain Glaukos (GKOS) Stock for Now [Yahoo! Finance]
4/12
11:02 am
gkos
Glaukos (GKOS) Gains Nearly 25% YTD: What's Driving the Rally? [Yahoo! Finance]
Low
Report
Glaukos (GKOS) Gains Nearly 25% YTD: What's Driving the Rally? [Yahoo! Finance]
4/11
11:09 am
gkos
Is Now The Time To Look At Buying Glaukos Corporation (NYSE:GKOS)? [Yahoo! Finance]
Low
Report
Is Now The Time To Look At Buying Glaukos Corporation (NYSE:GKOS)? [Yahoo! Finance]
4/11
08:06 am
gkos
Glaukos Co. (NYSE: GKOS) had its price target raised by analysts at Mizuho from $85.00 to $100.00. They now have a "neutral" rating on the stock.
Low
Report
Glaukos Co. (NYSE: GKOS) had its price target raised by analysts at Mizuho from $85.00 to $100.00. They now have a "neutral" rating on the stock.
4/10
07:00 am
gkos
Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
Medium
Report
Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
4/8
11:23 am
gkos
Glaukos Co. (NYSE: GKOS) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $110.00 price target on the stock.
Low
Report
Glaukos Co. (NYSE: GKOS) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $110.00 price target on the stock.
4/4
01:37 pm
gkos
Glaukos' (GKOS) iDose TR Receives Permanent J- Code From CMS [Yahoo! Finance]
Low
Report
Glaukos' (GKOS) iDose TR Receives Permanent J- Code From CMS [Yahoo! Finance]
4/3
12:36 pm
gkos
Glaukos gains on permanent J-code for iDose TR [Seeking Alpha]
Low
Report
Glaukos gains on permanent J-code for iDose TR [Seeking Alpha]
4/3
09:31 am
gkos
Glaukos Co. (NYSE: GKOS) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $110.00 price target on the stock.
Medium
Report
Glaukos Co. (NYSE: GKOS) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $110.00 price target on the stock.
4/3
07:09 am
gkos
Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant) [Yahoo! Finance]
Medium
Report
Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant) [Yahoo! Finance]
4/3
07:00 am
gkos
Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
Medium
Report
Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
4/1
07:18 am
gkos
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting [Yahoo! Finance]
Low
Report
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting [Yahoo! Finance]
4/1
07:00 am
gkos
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
Low
Report
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
3/26
04:29 pm
gkos
Center For Sight Implants New FDA-Approved iDose®TR Device [Yahoo! Finance]
Medium
Report
Center For Sight Implants New FDA-Approved iDose®TR Device [Yahoo! Finance]
3/25
08:45 am
gkos
Glaukos Co. (NYSE: GKOS) had its price target raised by analysts at Citigroup Inc. from $107.00 to $120.00. They now have a "buy" rating on the stock.
Low
Report
Glaukos Co. (NYSE: GKOS) had its price target raised by analysts at Citigroup Inc. from $107.00 to $120.00. They now have a "buy" rating on the stock.
3/25
08:19 am
gkos
Translational Vision Science and Technology Journal Publishes RadiusXR's NOVA Clinical Trial, Demonstrating Industry-Leading Accuracy and Innovation in Visual Field Testing for Virtual Reality Perimetry [Yahoo! Finance]
Low
Report
Translational Vision Science and Technology Journal Publishes RadiusXR's NOVA Clinical Trial, Demonstrating Industry-Leading Accuracy and Innovation in Visual Field Testing for Virtual Reality Perimetry [Yahoo! Finance]
3/22
03:44 pm
gkos
Glaukos Co. (NYSE: GKOS) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $110.00 price target on the stock.
Low
Report
Glaukos Co. (NYSE: GKOS) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $110.00 price target on the stock.
3/22
12:58 pm
gkos
Glaukos (GKOS) Down 4.3% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
Low
Report
Glaukos (GKOS) Down 4.3% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
3/4
07:56 am
gkos
Celanese (CE) Announces Commercial Launch of Glaukos' iDose TR [Yahoo! Finance]
Low
Report
Celanese (CE) Announces Commercial Launch of Glaukos' iDose TR [Yahoo! Finance]
2/29
09:19 am
gkos
Celanese Announces Commercial Launch of Glaukos' iDose® TR (Travoprost Intracameral Implant) Using Celanese's VitalDose® Ethylene Vinyl Acetate (EVA) [Yahoo! Finance]
Medium
Report
Celanese Announces Commercial Launch of Glaukos' iDose® TR (Travoprost Intracameral Implant) Using Celanese's VitalDose® Ethylene Vinyl Acetate (EVA) [Yahoo! Finance]
2/27
02:17 am
gkos
Glaukos Corp Director Mark Foley Sells 4,560 Shares [Yahoo! Finance]
Low
Report
Glaukos Corp Director Mark Foley Sells 4,560 Shares [Yahoo! Finance]
2/27
02:03 am
gkos
Glaukos Co. (NYSE: GKOS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Glaukos Co. (NYSE: GKOS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
2/22
11:37 am
gkos
Glaukos Co. (NYSE: GKOS) had its price target raised by analysts at Wells Fargo & Company from $83.00 to $103.00. They now have an "overweight" rating on the stock.
Low
Report
Glaukos Co. (NYSE: GKOS) had its price target raised by analysts at Wells Fargo & Company from $83.00 to $103.00. They now have an "overweight" rating on the stock.